The North American transcranial dopplers Market is mainly driven by the rising incidences of autoimmune and cardiovascular diseases and brain disorders. The North American TCD market was valued at $13.21 million in 2013 and is projected to grow at a CAGR of 4.9 to reach $16.74 million by 2018.